肝干细胞在损伤后肝再生中的作用及其对肝癌细胞的作用研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
成体肝内源性肝干细胞、肝外源性肝干细胞和肝细胞在肝再生中的相对角色是肝再生领域亟待阐明的核心命题之一,我们曾提出肝流域假设试图阐明之。本部分实验应用组织病理(肝细胞大核分裂相和小核分裂相、小胆管/赫令氏管/卵圆细胞增生等)、组织原位绿色荧光及免疫组化观察经致死剂量照射后性别交叉骨髓移植(或性别交叉性腺移植)小鼠不给予其它处理、给予假手术、给予野百合碱(Monocrotaline, MCT)抑制肝细胞分裂增殖、定期多次给予2/3切肝、给予MCT抑制肝细胞分裂增殖然后定期多次给予2/3切肝、给予反复CCl4损伤以及给予MCT抑制肝细胞分裂增殖的同时给予反复CCl4损伤。
     1.1性别交叉骨髓移植(♂GFP+ C57小鼠骨髓移植到经致死剂量照射的♀普通C57小鼠)后存活小鼠分入对照组,存活6周后开始观察,发现外周血内有核细胞基本上全部发绿色荧光,肝窦内单个核细胞基本上发绿色荧光,汇管区小胆管附近小细胞少数发绿色荧光,而肝板内肝细胞仅偶见个别发绿色荧光;这可能支持既往文献中两种争执观点中的一种:骨髓源肝干细胞在无明显肝损伤的情况下可以以极小的比例参与肝细胞的生理更新。假手术组(打开腹腔、不予2/3切肝、再关闭腹腔)与上述对照组所观察到的结果相似。
     1.2给予MCT抑制肝细胞分裂增殖者,发绿色荧光的肝板内肝细胞相对于上述对照组增多;此时MCT抑制成熟肝细胞分裂增殖,肝细胞的更新只能通过汇管区附近的肝内、外源性肝干细胞增生分化进行,此时能观察到汇管区附近少数小细胞(包括个别小胆管细胞)和与汇管区不直接邻接的肝板内甚至中央静脉附近的肝板内少数小细胞和肝细胞发绿色荧光,提示经血液循环而来的骨髓源性(肝外源性)肝干细胞可能有部分补充到汇管区附近肝内源性肝干细胞的行列中,也有部分在自小叶周边向中央静脉的肝窦血流路径上直接钻入肝板并可以增生分化为成熟肝细胞。
     1.3定期多次给予2/3切肝,肝再生时出现大量的大核分裂相,与对照组相比出现了轻微小胆管/COH细胞增生现象以及在肝窦部位之外偶尔出现少数小核分裂相;在成熟肝细胞分裂增生能力不被抑制的情况下,尽管肝再生主要由成熟肝细胞分裂增生完成,但肝内固有的肝内源性肝干细胞甚至肝外源性肝干细胞也在一定程度上参与了肝再生;并且肝内源性肝干细胞可以由肝外源性肝干细胞转变补充而来。
     1.4给予MCT抑制肝细胞分裂增殖者,再定期多次给予2/3切肝,出现明显的小胆管/COH细胞增生和卵圆细胞增生现象,大核分裂相难以观察到而小核分裂相明显增多;发绿色荧光的肝板内肝细胞、小胆管/COH细胞和卵圆细胞相对于上述对照组明显增多。这些观察结果提示:卵圆细胞既可来源于该鼠肝脏原来固有的小胆管/COH细胞的增生(不发绿色荧光者),也可来源于由骨髓源性(肝外源性)肝干细胞补充而来的小胆管/COH细胞及其附近小细胞的增生(发绿色荧光者)。增生小胆管上皮细胞免疫组化标记CK19阳性;卵圆细胞免疫组化标记AFP阴性或微弱阳性,体积较大者(即已转变为小肝细胞者)明显阳性,成熟肝细胞为阴性。
     1.5给予反复CCl4损伤、诱导肝纤维化并与对照组对比观察后发现,肝组织内发绿色荧光的细胞明显增多,其中大部分是肝细胞变性损伤所伴随的单个核小细胞的浸润,但发绿色荧光的肝细胞也逐渐增多;且在少数汇管区附近可见卵圆细胞增生;大核分裂相可以见到但明显少于不予MCT抑制肝细胞分裂增殖的单纯2/3切肝组,小核分裂相明显增多;提示CCl4肝损伤条件下,成熟肝细胞广泛变性甚至小灶坏死、分裂增生能力不如反复切肝组的肝细胞,肝内、外源性肝干细胞参与肝再生的程度明显高于反复2/3切肝组。
     1.6若给予反复CCl4损伤的同时用MCT抑制肝细胞分裂增殖,汇管区与小叶交界处小胆管和卵圆细胞增生反应趋于明显,部分小胆管/卵圆细胞增生灶不发绿色荧光而部分小胆管/卵圆细胞增生灶则发绿色荧光,肝组织内出现较多的肝细胞发绿色荧光;肝内炎症反应细胞样细胞和汇管区附近部分小细胞也可发绿色荧光。在CCl4损伤的情况下,肝内、外源性肝干细胞均能有效地参与肝再生,肝外源性肝干细胞还能补充到小胆管细胞中(原属于肝内源性肝干细胞存在的部位)。若停用CCl4,肝纤维化病变可逐步缓解消失,这与当前国外报道的现象相似。
     2.与肝流域假设同时期提出的假说还有干细胞池假说(包括性腺干细胞池假说),为此我们进行了GFP+性腺移植实验研究,结果发现性腺移植后存活小鼠给予反复2/3切肝或者CCl4损伤者外周血涂片极难找到发绿色荧光的单个核细胞;假如与此同时还加用了MCT抑制肝细胞分裂增殖,在出现明显的小胆管/COH细胞和卵圆细胞增生现象的同时,仅偶尔可在个别例小鼠的肝组织整张切片内找到极个别发绿色荧光的单个核小细胞或肝板内肝细胞。提示干细胞池中的性腺干细胞在肝细胞的生理更新或病理损伤后肝再生中基本上不起作用。
     本实验基本验证了肝流域假设的部分内容,肝内、外源性肝干细胞和肝细胞均参与肝细胞更新再生,尤其当肝细胞损伤、再生能力不足时,肝内、外源性肝干细胞就会在肝再生中发挥更重要作用(其中,骨髓源性<肝外源性>肝干细胞还可以补充到肝内源性肝干细胞中)。
     第二部分
     本课题组在进行第一部分实验的过程中,有几只照射后骨髓移植小鼠因故委托他人饲养照顾时误给了N-亚硝基二乙胺(N-nitrosodiethylamine,DEN)、18周后发现有肝肿瘤形成,并且在肿瘤与正常肝组织交界处观察到发绿色荧光的小细胞(骨髓来源细胞)。根据这个意外发现,我们考虑到干细胞在肿瘤细胞附近的出现对肿瘤细胞到底有何种影响?为了给出相应的答案,我们进行了第二部分的实验。第二部分实验通过共培养CBRH-7919大鼠肝癌细胞和WB-F344大鼠肝干细胞,发现了WB-F344大鼠肝干细胞在肝癌微环境中通过TGF-?/Smad途径促进CBRH-7919大鼠肝癌细胞凋亡进而抑制了CBRH-7919大鼠肝癌细胞的生长,此结果为临床诊治肝癌患者提供了新的理论依据。具体简要结果如下:
     流失细胞仪分析结果表明,随着共培养体系中WB-F344大鼠肝干细胞所占比例的提高,CBRH-7919大鼠肝癌细胞的凋亡率明显增加,说明CBRH-7919大鼠肝癌细胞的致瘤性可以被WB-F344大鼠肝干细胞抑制;软琼脂克隆形成实验的结果表明,随着共培养体系中WB-F344大鼠肝干细胞所占比例的提高,CBRH-7919大鼠肝癌细胞的克隆形成数量明显减少,说明CBRH-7919大鼠肝癌细胞的致瘤性可以被WB-344大鼠肝干细胞抑制;四组transwell细胞侵袭试剂盒检测细胞侵袭能力的结果均为阴性,表明WB-F344大鼠肝干细胞对CBRH-7919大鼠肝癌细胞的侵袭能力并没有明显的影响;半定量RT-PCR分析结果表明,随着共培养体系中WB-F344大鼠肝干细胞所占比例的提高,CBRH-7919大鼠肝癌细胞中的PTEN mRNA的表达水平增高,而BMP4,c-Myc和Bcl-2 mRNA的表达水平则降低,这更进一步证明了CBRH-7919大鼠肝癌细胞的致瘤性可以被WB-F344大鼠肝干细胞抑制;Western blot分析结果表明,随着共培养体系中WB-F344大鼠肝干细胞所占比例的提高,CBRH-7919大鼠肝癌细胞中的Smad 4和TGF-?RII蛋白表达水平上升,这则证明了WB-F344大鼠肝干细胞可能通过调节TGF-?/Smad途径促进CBRH-7919大鼠肝癌细胞的凋亡,进而抑制CBRH-7919大鼠肝癌细胞的致瘤性;在荷瘤小鼠模型建立第30天,随着共培养体系中WB-F344大鼠肝干细胞所占比例的提高,肝脏肿瘤体积明显减小,荷瘤小鼠的生存期明显延长,Kaplan Meier生存分析皆有统计学意义,这些结果表明WB-F344大鼠肝干细胞可抑制裸鼠体内CBRH-7919大鼠肝癌细胞的致瘤性;与实验组相比,对照组肿瘤恶性程度高,核/浆比例高,大片区域出现单核或者多核瘤巨细胞,并且在实验组中,随着共培养体系中起始WB-F344大鼠肝干细胞的比例增高,肿瘤细胞异型性降低,这表明在荷瘤小鼠模型中,CBRH-7919大鼠肝癌细胞的致瘤性可以被WB-F344大鼠肝干细胞抑制。
That the relative roles of intrahepatic/extrahepatic stem cells and hepatocytes in liver regeneration in adult was still one core question urgently to answer in the liver regeneration field. And we had ever proposed liver valley hypothesis to elucidate it.Histiocytopathology(big hepatocyte karyomitoses,small karyomitoses and small bile ducts/Hering's canal/oval cells proliferation and so on),frozen section green fluorescence and immunohistochemistry in situ were employed to dynamicly observe:the mouse survivals after cross-sex GFP+ bone marrow transplantation which were irradiated before transplantation, or cross-sex GFP+ gonad transplantation,were administrated without other treatment,with the sham operation,with monocrotaline to inhibit hepatocytes division and growth,with 2/3 partial hepatectomy repeatly,with monocrotaline and 2/3 partial hepatectomy repeatly,with CCl4 injury after injection of monocrotaline to inhibit hepatocytes division and growth or not.
     1.1 The mice were divided to the control group after cross-sex bone marrow transplantation that the bone marrow of GFP+ C57 male mice were transplanted into ordinary C57 female mice irradiated with lethal dose before transplanted.After survial for six weeks,we found that karyocytes in the peripheral blood had green fluorescene on the whole and mononuclearcells in the hepatic sinus had green fluorescene mainly.A few small cells around the small bile duct in the portal area had green fluorescene.And only few hepatocytes in the hepatic plate had green fluorescene by chance. These might support literatures that hepatic stem cells origing from bone marrow could participate in the physiological renewal of hepatocytes in very small ratio without obvious liver injury.The results from the sham operation group that was opened the abdominal cavity ,not given PH and closed the abdominal cavity were similar with those of the control group.
     1.2 The mice were given cross-sex bone marrow transplantation and monocrotaline which inhibited mature hepatocytes division and growth.Hepatocytes in the hepatic plate with green fluorescene were obviously more than those of the control group.Monocrotaline could inhibit division and growth of hepatocytes and the physiological renewal of hepatocytes was fulfilled by proliferation and differentiation of extrahepatic/intrahepatic stem cells in the portal area at this time.And we could find that a few small cells including the bile duct in or around the portal area with green fluorescence.And a few small cells and hepatocytes in the hepatic plate indirect approximation with the portal area and in the hepatic plate near the central veins were also with green fluorescence.These hinted that bone marrow (extrahepatic) stem cells origining from the blood circulation could replenish intrahepatic stem cells near the portal area,and some could go through the hepatic plate from the hepatic sinusoid bloodstream pathway from perilobule to the central vein and could proliferate and differentiate to mature hepatocytes.
     1.3 The mice were given PH many times regularly after cross-sex bone marrow transplantation and there were a lot of big karyomitosis with liver regeneration.But contrasting with the control group,there were a little proliferation of the small bile duct/COH and a few small karyomitosis besides the hepatic sinus by change.Our results hinted that not only intrahepatic stem cells but also extrahepatic stem cells participated in the liver regeneration in some degree,notwithstanding liver regeneration were accomplished by mature hepatocytes mainly when the capability of division and hyperplasia of mature hepatocytes was not inhibited.And intrahepatic stem cells could be recruited by extrahepatic stem cells.
     1.4 The mice were given monocrotaline which inhibited division and growth of hepatocytes after cross-sex bone marrow transplantation and given PH many times regularly.There were more obvious proliferation of the small bile duct/COH and OCs.We could nearly not find the big karyomotisis and the small karyomotisis were obviously more.There were more hepatocytes in the hepatic plate,the small bile duct/COH and OCs with green fluorescent than those of the control group.These observation hinted that OCs could origin from the resident small bile duct/COH without green fluorescence and from the small bile duct/COH and small cells nearby from bone marrow with green fluorescence.Cytokeratin 19 is positive in the small bile ducts with proliferation in immunohistochemisty.AFP is negative or weak positive in the oval cells,obviously positive in the bigger cells which had already changed to the small hepatocytes,and negative in the hepatocytes.
     1.5 The mice were given CCl4 after cross-sex bone marrow transplantation to induce hepatic fibrosis and contrasted with the control group.The cells with green fluorescence were more and majority were infiltration of the single nucleus small cells with degeneration and injury of hepatocytes.Hepatocytes with green fluorescence were more.There were more OCs regeneration around a few portal area.There were some big karyomitosis but obviously few than those of the PH group without monocrotaline which inhibited division and growth of hepatocytes.And there were obviously more small karyomitosis.These hinted that there were more extrahepatic/intrahepatic stem cells participating in the liver regeneration than those of the PH group,using CCl4 with more widespread degeneration of mature hepatocytes and even focus necrosis and the capability of division and regeneration of hepatocytes not more than that of the PH group.
     1.6 If we used monocrotaline which inhibited division and growth of hepatocytes at the same time,the proliferation reaction in the juncture of the lobule and the small bile duct was obvious.Some proliferation focus of the small bile duct/OC had not green fluorescence and some had.There were more hepatocytes with green fluorescence.The inflammatory reaction cells and some small cells near the portal area could have green fluorescence.Extrahepatic/intrahepatic stem cells could effectivly participate in liver regeneration with CCl4.And extrahepatic stem cells could replenish the small bile duct which were the position of intrahepatic stem cells.If we stoped CCl4,hepatic fibrosis could relieve step by step.If we gave these mice the GFP+ bone marrow cells in tail vein,hepatic fibrosis could also relieve step by step,which was similar with the correlated reports before.
     2. There were stem cell pool hypothesis including gonad stem cell pool hypothesis,raising about the same time with liver valley hypothesis.And we took research with GFP+ gonad transplantation.And we found that there were nearly not mononuclearcells with green fluorescent in the peripheral blood smear in mice with PH or CCl4 after gonad transplantation.If we took monocrotaline which inhibited hepatocyte division and growth,there were conspicuous regeneration of the small bile duct/COH and OCs and we could find very few mononuclearcells or hepatocytes with green fluorescent in the liver plate of the whole liver tissue section in a few mice.These hinted that gonad stem cells did nearly not play a part in the physiological renewal of hepatocytes or liver regeneration after pathological injury.
     The liver valley hypothesis was preliminary verificated based on the our experiment that both intrahepatic/extrahepatic stem cells and hepatocytes contributed to the liver regeneration,in which hepatic stem cells play a more impportant role when the hepatocytes were injured and their regeneration capacity decreased, especially the stem cells from bone marrow considering that extrahepatic stem cells could fill up intrahepatic liver stem cells.
     The Second Part
     We entrusted other person to breed our mice,and he made a mistake to give our mice after bone marrow transplantation with lethal irradiation N-nitrosodiethylamine(DEN) in our first part experiment.And we found tumor in mice after 18 weeks,and there were some the small cells(cells from bone marrow) with the green fluorescence in the borderline of the tumor and the normal tissue.Based on this discovery by chance,we thought what role the stem cells were around the tumor?In order to get the answer,we did the second part experiment.We cultured the CBRH-7919 hepatic carcinoma cells and WB-344 hepatic stem cells of rat together,and we found that WB-344 rat hepatic stem cells promoted apoptosis of CBRH-7919 rat hepatic carcinoma cell and inhibited it grew with the TGF-?/Smad way in the microenvironment of the hepatic cancer.And this result gave new theory base to treat the hepatic cancer patients.The specific and concise results were as followed.
     The result from flow cytometer indicated that the apoptosis rate of CBRH-7919 rat hepatic carcinoma cell increased apparently with the increment proportion of the WB-344 rat hepatic stem cells in the co-culture system.This result indicated that WB-344 rat hepatic stem cells could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells.The soft agar clone formation experiment indicated that with the increment proportion of the WB-344 rat hepatic stem cells in the co-culture system,the amount of the CBRH-7919 rat hepatic carcinoma cells clones decreased apparently.This result indicated that WB-344 rat hepatic stem cells could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells.The four transwell cell infestation experiment indicated that the infestation ability were all negative.This result indicated WB-344 rat hepatic stem cells did not affect the infestation ability of CBRH-7919 rat hepatic carcinoma cells.Demi-quantitation RT-PCR analysis displayed that PTEN was upregulation and bone morphogenetic protein 4 (BMP4), Bcl-2, and c-Myc was downregulation in CBRH-7919 rat hepatic carcinoma cells with the increment proportion of the WB-F344 rat hepatic stem cells in the co-culture system.This result indicated that WB-344 hepatic stem cell could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells.The result from Western blot hybridization analysis indicated that with the increment proportion of the WB-344 rat hepatic stem cells in the co-culture system,the expression level of Smad 4 and TGF-?RII increased.This result indicated that WB-344 rat hepatic stem cells could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells regulating the TGF-?/Smad way to promote the apoptosis of CBRH-7919 rat hepatic carcinoma cells.In the thirtieth days,in the mice with the tumor with the increment proportion of WB-344 rat hepatic stem cells in the co-culture system,the volume of tumor decreased,life span increased conspicuously and Kaplan Meier survival analysis had statistics significance.This results indicated that WB-F344 rat hepatic stem cells could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells in nude mice in vivo.Contrasting with the experiment groups,the malignancy grade of tumor increased,the ration of nucleus to cytoplasm increased,there were some mononuclear or polynuclear cells in many area in the conrol group,and the heteromorphism of tumor cells degraded with the increment proportion of the WB-344 rat hepatic stem cells in the co-culture system.This results indicated that WB-F344 rat hepatic stem cells could inhibit the tumorigenicity of CBRH-7919 rat hepatic carcinoma cells.
引文
[1]Stocker E,Wullstein HK,Brau G.Capacity of regeneration in liver epithelia of juvenile,repeated partially hepatectomized rats;Autoradiographic studies after continous infusion of 3H-thymidine.Virchows Arch B Cell Pathol,1973,14:93
    [2]Michalopoulos GK,DeFrances MC.Liver Regeneration.Science,1997,276:60-66
    [3]Jauregui HO.Hepatocyte cell lines as the biological component of liver support.Artif Organs,2001,25:509-512
    [4]Wilson JW,Leduc EH.Role of cholangioles in restoration of the liver of the mouse after dietary injury.J pathol Bacteriol,1958,76:441-449
    [5]Zajicek G,Oren R,Weinreb MJ.The streaming liver.Liver,1985,5:293-300
    [6]Xiao JC,Jin XL,Ruck P,Adam A,Kaiserling E.Hepatic progenitor cells in human liver cirrhosis:immunohistochemical,electron microscopic and immunofluorencence confocal microscopic findings.W J Gastroenterology,2004,10(8):1208-1211
    [7]Fellous TG,Islam S,Tadrous PJ,et al.Locating the stem cell niche and tracing hepatocyte lineages in human liver.Hepatology,2009,49:1655-1663
    [8]Kuwahara R,Kofman AV,Landis CS,et al.The hepatic stem cell niche:identification by label-retaining cell assay.Hepatology,2008,47:1994-2002
    [9]Fu PP, Xia QS, Lin G,et al.Genotoxic pyrrolizidine alkaloids-Mechanisms leading to DNA adduct formation and tumorigenicity.Int J Mol Sci,2002, 3:948-964
    [10]Gordon GJ,Coleman WB,Hixson DC,et al.Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response.Am J Pathol,2000,156:607-619
    [11]Conzelmann LO,Hines IN,Kremer M,et al.Extrahepatic cells contribute to the progenitor/stem cell response following reduced-size liver transplantation in mice.Exp Biol Med,2007,232:571-580
    [12]Brulport M,Schormann W,Bauer A,et al.Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers.Hepatology,2007,46:861-870
    [13]Sun ZL,Zhang XY,Locke JE,et al.Recruitment of host progenitor cells in rat liver transplants.Hepatology,2009,49:587-597
    [14]Eguchi S,Takatsuki M,Yamanouchi K,et al.Regeneration of graft livers and limited contribution of extrahepatic cells after partial liver transplantation in humans.Dig Dis Sci,2010,55(3):820-5
    [15]Tomiyama K,Miyazaki M,Nukui M,et al.Limited contribution of cells of intact extrahepatic tissue origin to hepatocyte regeneration in transplanted rat liver.Transplantation,2007,83:624-630
    [16]Petersen BE,Bowen WC,Patrene KD,et al.Bone Marrow as a Potential Source of Hepatic Oval Cells.Science, 1999, 284:1168-1170
    [17]Neil D, Theise ND, Badve S, et al.Derivation of hepatocytes from Bone Marrow cell in mice after radiation-induced myeloablation.Hepatology, 2000, 31:235-240
    [18]Almeida-Porada G,Porada CD,Chamberiain J,Torabi A and Zanjani ED.Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood,2004,104(8):2582-2590
    [19]Oh SH,Witek RP,Bae SH,et al.Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.Gastroenterology,2007,132:1077-1087
    [20]Chamberlain J,Yamagami T,Colletti E,et al.Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep.Hepatology,2007,46:1935-1945
    [21]Cho KA,Ju SY,Cho SJ,et al.Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow.Cell Biology International,2009,33:772-777
    [22]Stadtfeld M, Graf T.Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development,2005,132(1):203-13
    [23]Tonkin JN,Knight B,Curtis D,et al.Bone marrow cells play only a very minor role in chronic liver regeneration induced by a choline-deficient,ethionine-supplemented diet.Stem Cell Research,2008,1:195-204
    [24]Rountree CB,Wang XL,Ge SD,et al.Bone marrow fails to differentiate into liver epithelium during murine development and regeneration.Hepatology,2007,45:1250-1260
    [25]Popp FC,Slowik P,Eggenhofer E,et al.No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury.Stem Cells,2007,25:639-645
    [26]Campli CD,Piscaglia AC,Giuliante F,et al.No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure.Transplantation Proceedings,2005,37:2563-2566
    [27]Su J, Yao YC, Yu HY, Zhu HY, Wang XM, Wang ZH and Hu YP.Clonogenic colony-forming ability of hepatic stem cells in the spleens of mice.Chinese Sci Bulletin,2002,47(3):211-213
    [28]Petersen BE, Grossbard B, Hatch H, et al.Mouse A6-positeve hepatic oval cells also express several hematopoietic stem cell markers.Hepatology,2003,37:632-640
    [29]Shu SN,Wei L,Wang JH,Zhan YT,Chen HS,Wang Y.Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells.W J Gastroenterology,2004,10(19):2818-2822
    [30]Wang C,Chelly MR,Chai N,Tan Y, Li H, Farkas DL,Demetriou AA.Transcriptomic fingerprinting of bone marrow-derived hepatic beta(2)m(-)/Thy-1(+) stem cells.Biochem Biophys Res Commun,2005,327(1):252-260
    [31]Stamp L,Crosby HA,Hawes SM,Strain AJ,Pera,MF.A novel cell-surface marker found on human embryonic hepatoblasts and a subpopulation of hepatic biliary epithelial cells.Stem Cells,2005,23(1):103-12
    [32]Kucia M, Ratajczak J, Ratajczak MZ.Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells.Biol Cell.2005,97(2):133-46
    [33]Nardi NB.All the adult stem cells,where do they all come from?An external source for organ-specific stem cell pools.Med Hypotheses.2005,64(4):811-7
    [34]余宏宇,李文林,谢东甫,张朵,肖承志,孙志勇,何金,孙静,苏娟,李建秀,朱明华,胡以平.小鼠单纯肝切除后再生肝组织内大小核分裂相和卵圆细胞的观察.第二军医大学学报,2005,26(3):261-266
    [35]Higgins GM,Anderson RM.Experimental pathology of the liver;Restoration of the liver of the white rat following partial surgical removal.AMA Arch Pathol,1931,12:186-202
    [36]Cantz T,Manns MP,Ott M.Stem cells in liver regeneration and therapy.Cell Tissue Res,2008,331(1):271-82
    [37]Moriya K,Yoshikawa M,Ouji Y,Saito K,Nishiofuku M,Matsuda R,Ishizaka S,Fukui H.Embryonic stem cells reduce liver fibrosis in CCl4-treated mice.Int J Exp Pathol,2008,89(6):401-9
    [38]Kuo TK,Hung SP,Chuang CH,Chen CT,Shih YR,Fang SC,Yang VW,Lee OK.Stem cell therapy for liver disease:parameters governing the success of using bone marrow mesenchymal stem cells.Gastroenterology,2008,134(7):2111-21,2121.e1-3
    [39]Chang YJ,Liu JW,Lin PC,et al.Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis.Life Sciences,2009,85:517-525
    [40]Witek RP,Fisher SH,Petersen BE.Monocrotaline, an Alternative to Retrorsine-Based Hepatocyte Transplantation in Rodents.Cell Transplantation,2005,14:41-47
    [41]Theise ND,Badve S,Saxena R,Henegariu O,Sell S,Crawford JM,Krause DS.Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.Hepatology,2000,31(1):235-40
    [1]Tsao MS,Smith JD,Nelson KG,et al.A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells.Exp Cell Res,1984,154(1):38-52
    [2]Silva MT,Do VA,Dos SN.Fish and apoptosis:studies in disease and pharmaceutical design.Curr Pharm Des,2008,14(2):170-183
    [3]Kingsley DM.What do BMPs do in mammals?Clues from the mouse short-ear mutation.Trends Genet,1994,10(1):16-21
    [4]Massague J.TGF-beta signal transduction.Annu Rev Biochem,1998,67:753-791
    [5]Qiao L,Xu Z,Zhao T,et al.Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.Cell Res,2008,18(4):500-507
    [6]Zhong XG,He S,Yin W,et al.Selective tropism of liver stem cells to hepatocellular carcinoma in vivo.World J Gastroenterol,2007,13(28):3886-3891
    [7]Chen XC,Wang R,Zhao X, et al.Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs. Carcinogenesis,2006,27(12):2434-2441
    [8]Nakamizo A,Marini F,Amano T,et al.Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.Cancer Res,2005,65(8):3307-3318
    [9]Qiao L,Zhao TJ,Wang FZ,et al.NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.Acta Pharmacol Sin,2008,29(3):333-340
    [10]Studeny M,Marini FC,Dembinski JL,et al.Mesenchymal stem cells:potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.J Natl Cancer Inst,2004,96(21):1593-1603
    [11]Chiba T,Zheng YW,Kita K,et al.Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.Gastroenterology,2007,133(3):937-950
    [12]Reya T,Clevers H.Wnt signalling in stem cells and cancer. Nature,2005,434(7035):843-850
    [13]Miele L,Miao H,Nickoloff BJ.NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets,2006,6(4):313-323
    [14]Maegdefrau U,Amann T,Winklmeier A,et al.Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.J Pathol,2009,218(4):520-529
    [15]Raida M, Heymann AC, Gunther C, et al.Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.Int J Mol Med,2006,18(4):735-739
    [16]Nguyen LN,Furuya MH,Wolfraim LA,et al.Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology,2007,45(1):31-41
    [17]Wandzioch E,Zaret KS.Dynamic signaling network for the specification of embryonic pancreas and liver progenitors.Science,2009,324(5935):1707-1710
    [18]Blum R,Gupta R,Burger PE,et al.Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer.PLoS One,2009,4(5):e5722
    [19]Neth P,Ciccarella M,Egea V,et al.Wnt signaling regulates the invasion capacity of humanmesenchymal stem cells.Stem Cells,2006,24(8):1892-1903
    
    [1]Wilson JW,Leduc EH.Role of cholangioles in restoration of the liver of the mouse after dietary injury.J Pathol Bacteriol,1958,76(2):441-449
    [2]Petersen BE,Goff JP,Greenberger JS,Michalopoulos GK.Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat.Hepatology,1998,27(2):433-445
    [3]Braun KM,Thompson AW,Sandgren EP.Hepatic microenvironment affects oval cell localization in albumin-urokinase-type plasminogen activator transgenic mice.Am J Pathol,2003,162(1):195-202
    [4]Sakamoto T,Liu Z,Murase N,Ezure T,Yokomuro S,Poli V,Demetris AJ.Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.Hepatology,1999,29(2):403-411
    [5]Petersen BE,Bowen WC,Patrene KD,Mars WM,Sullivan AK,Murase N,Boggs SS, Greenberger JS,Goff JP.Bone marrow as a potential source of hepatic oval cells.Science,1999,284(5417):1168-1170
    [6]Theise ND,Nimmakayalu M,Gardner R,Illei PB,Morgan G,Teperman L,Henegariu O, Krause DS.Liver from bone marrow in humans.Hepatology,2000,32(1):11-16
    [7]Theise ND,Badve S,Saxena R,Henegariu O,Sell S,Crawford JM,Krause DS.Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology,2000,31(1):235-240
    [8]Wang X,Foster M,Al-Dhalimy M,Lagasse E,Finegold M,Grompe M.The origin and liver repopulating capacity of murine oval cells.Mol Ther,2003,7(5):S75-S75
    [9]Davies RA,Knight B,Tian YW,Yeoh GC,Olynyk JK.Hepatic oval cell response to the choline-deficient,ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor.Carcinogenesis,2006,27(8):1607-1616
    [10]Suzuki A,McCall S,Choi SS,Sicklick JK,Huang J,Qi Y,Zdanowicz M,Camp T,Li YX, Diehl AM.Interleukin-15 increases hepatic regenerative activity.J Hepatol,2006, 45(3):410-418
    [11]Szabo E,Lodi C,Korpos E,Batmunkh E,Rottenberger Z,Deak F, Kiss I,Tokes AM,LotzG,Laszlo V,et al.Expression of matrilin-2 in oval cells during rat liver regeneration.Matrix Biol,2007,26(7):554-560
    [12]Mitaka T,Mikami M,Sattler GL,Pitot HC,Mochizuki Y.Small cell colonies appear in the primary culture of adult rat hepatocytes in the presence of nicotinamide and epidermal growth factor.Hepatology,1992,16(2):440-447
    [13] Alison MR,Golding MH,Sarraf CE.Pluripotential liver stem cells:facultative stem cells located in the biliary tree.Cell Prolif,1996,29(7):373-402
    [14]Shafritz DA.Rat liver stem cells:prospects for the future.Hepatology,2000, 32(6):1399-1400
    [15]He ZP,Tan WQ,Tang YF,Feng MF.Differentiation of putative hepatic stem cells derived from adult rats into mature hepatocytes in the presence of epidermal growth factor and hepatocyte growth factor.Differentiation,2003,71(4-5):281-290
    [16]Dabeva MD,Petkov PM,Sandhu J,Oren R,Laconi E,Hurston E,Shafritz DA. Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver.Am J Pathol,2000,156(6):2017-2031
    [17]Suzuki A,Zheng YW,Kaneko S,Onodera M,Fukao K,Nakauchi H,Taniguchi H.Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver.J Cell Biol,2002,156(1):173-184
    [18]Dan YY,Riehle KJ,Lazaro C,Teoh N,Haque J,Campbell JS,Fausto N.Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages.Proc Natl Acad Sci,2006,103(26):9912-9917
    [19] Malhi H,Irani AN,Gagandeep S,Gupta S.Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes.J Cell Sci,2002,115(Pt 13):2679-2688
    [20]Forbes S,Vig P,Poulsom R,Thomas H,Alison M.Hepatic stem cells.J Pathol,2002, 197(4):510-518
    [21]Zheng YW,Taniguchi H.Diversity of hepatic stem cells in the fetal and adult liver. Semin Liver Dis,2003, 23(4):337-348
    [22]Baharvand H,Hashemi SM,Kazemi Ashtiani S,Farrokhi A.Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.Int J Dev Biol, 2006,50(7):645-652
    [23]Yamada T,Yoshikawa M,Kanda S,Kato Y,Nakajima Y,Ishizaka S,Tsunoda Y.In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green.Stem Cells,2002, 20(2):146-154
    [24]Hay DC,Zhao D,Ross A,Mandalam R,Lebkowski J,Cui W.Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells,2007,9(1):51-62
    [25]Fausto N,Campbell JS.The role of hepatocytes and oval cells in liver regeneration and repopulation.Mech Dev,2003,120(1):117-130
    [26]Yamamoto H,Quinn G,Asari A,Yamanokuchi H,Teratani T,Terada M,Ochiya T. Differentiation of embryonic stem cells into hepatocytes:biological functions and therapeutic application.Hepatology,2003,37(5):983-993
    [27]Teratani T,Yamamoto H,Aoyagi K,Sasaki H,Asari A,Quinn G,Terada M,Ochiya T. Direct hepatic fate specification from mouse embryonic stem cells.Hepatology,2005, 41(4):836-846
    [28]Kronenwett R,Haas R.Differentiation potential of stem cells from bone marrow.Med Klin (Munich),2006,101 Suppl 1:182-185
    [29]Oh SH,Miyazaki M,Kouchi H,Inoue Y,Sakaguchi M,Tsuji T,Shima N,Higashio K, Namba M.Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro.Biochem Biophys Res Commun,2000,279(2):500-504
    [30]Lee KD,Kuo TK,Whang-Peng J,Chung YF,Lin CT,Chou SH,Chen JR,Chen YP,Lee OK.In vitro hepatic differentiation of human mesenchymal stem cells.Hepatology,2004, 40(6):1275-1284
    [31]Lange C,Bassler P,Lioznov MV,Bruns H, Kluth D, Zander AR, Fiegel HC.Hepatocytic gene expression in cultured rat mesenchymal stem cells.Transplant Proc,2005, 37(1):276-279
    [32]Menthena A,Deb N,Oertel M,Grozdanov PN,Sandhu J,Shah S,Guha C,Shafritz DA, Dabeva MD.Bone marrow progenitors are not the source of expanding oval cells in injuredliver.Stem Cells,2004, 22(6):1049-1061
    [33]Kohneh-Shahri N,Regimbeau JM,Terris B,Paradis V,Bralet MP,Coleman W,Butz G, Chouzenoux S,Houssin D,Soubrane O.Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model.Gastroenterol Clin Biol,2006, 30(3):453-459
    [34]Krakowski ML,Kritzik MR,Jones EM,Krahl T,Lee J,Arnush M,Gu D,Sarvetnick N. Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells.Am J Pathol,1999,154(3):683-691
    [35]Dabeva MD,Hwang SG,Vasa SRG,Hurston E,Novikoff PM,Hixson DC,Gupta S, Shafritz DA.Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver.P Natl Acad Sci,1997,94(14):7356-7361
    [36]Zulewski H,Abraham EJ,Gerlach MJ,Daniel PB,Moritz W,Muller B,Vallejo M,Thomas MK,Habener JF.Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes,2001,50(3):521-533
    [37]Kakinuma S,Tanaka Y,Chinzei R,Watanabe M,Shimizu-Saito K,Hara Y,Teramoto K, Arii S,Sato C,Takase K et al.Human umbilical cord blood as a source of transplantable hepatic progenitor cells.Stem Cells,2003,21(2):217-227
    [38]Kollet O,Shivtiel S,Chen YQ,Suriawinata J,Thung SN,Dabeva MD,Kahn J,Spiegel A, Dar A,Samira S,et al.HGF, SDF-1,and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.J Clin Invest,2003,112(2):160-169
    [39]Son BR,Marquez-Curtis LA,Kucia M,Wysoczynski M,Turner AR,Ratajczak J, Ratajczak MZ,Janowska-Wieczorek A.Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.Stem Cells,2006,24(5):1254-1264
    [40]Bjornson CR,Rietze RL,Reynolds BA,Magli MC,Vescovi AL.Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo.Science,1999, 283(5401):534-537
    [41]Clarke DL.Neural stem cells.Bone Marrow Transplant,2003,32 Suppl 1:S13-17
    [42]Wilson A,Butler PE,Seifalian AM.Adipose-derived stem cells for clinical applications: a review.Cell Prolif,2011,44(1):86-98
    [43]Sohni A,Verfaillie CM.Multipotent adult progenitor cells.Best Pract Res Clin Haematol,2011,24(1):3-11
    [44]Chramostova K,Vondracek J,Sindlerova L,Vojtesek B,Kozubik A,Machala M. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells.Toxicol Appl Pharmacol,2004,196(1):136-148
    [45]Oertel M,Menthena A,Chen YQ,Teisner B,Jensen CH,Shafritz DA.Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver.Gastroenterology,2008,134(3):823-832
    [46]Saito A,Nakayama K,Hara H.Mild zinc deficiency and dietary phytic acid accelerates the development of fulminant hepatitis in LEC rats.J Gastroenterol Hepatol,2007, 22(2):150-157
    [47]Suzuki A,Zheng YW,Fukao K,Nakauchi H,Taniguchi H.Clonal expansion of hepatic stem/progenitor cells following flow cytometric cell sorting.Cell Transplant,2001, 10(4-5):393-396
    [48]Avital I,Inderbitzin D,Aoki T,Tyan DB,Cohen AH,Ferraresso C,Rozga J,Arnaout WS,Demetriou AA.Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells.Biochem Biophys Res Commun,2001, 288(1):156-164
    [49]Qin AL,Zhou XQ,Zhang W,Yu H,Xie Q.Characterization and enrichment of hepatic progenitor cells in adult rat liver.World J Gastroenterol,2004,10(10):1480-1486
    [50]Yan ZY,An W,Wang P,Jia JD.Isolation and prelimary characterization of a kind of rat liver potential progenitor cells small round hepatic cells.Shi Yan Sheng Wu Xue Bao,2004, 37(6):475-481
    [51]Tsamandas AC,Antonacopoulou A,Kalogeropoulou C,Tsota I,Zabakis P,Giannopoulou E,Liava A,Tzelepi V,Tepetes K,Petsas T,et al.Oval cell proliferation in cirrhosis in rats.An experimental study.Hepatol Res,2007,37(9):755-764
    [52]Corcelle V,Stieger B,Gjinovci A,Wollheim CB,Gauthier BR.Characterization of twodistinct liver progenitor cell subpopulations of hematopoietic and hepatic origins.Exp Cell Res,2006,312(15):2826-2836
    [53]Weiss MC,Strick-Marchand H.Isolation and characterization of mouse hepatic stem cells in vitro.Semin Liver Dis,2003,23(4):313-324
    [54]Lowes KN,Croager EJ,Olynyk JK,Abraham LJ,Yeoh GC.Oval cell-mediated liver regeneration:Role of cytokines and growth factors.J Gastroenterol Hepatol,2003, 18(1):4-12
    [55]Omary MB,Ku NO,Toivola DM.Keratins:guardians of the liver.Hepatology,2002, 35(2):251-257
    [56]Lee HS,Sherley JL,Chen JJ,Chiu CC,Chiou LL,Liang JD,Yang PC,Huang GT,Sheu JC.EMP-1 is a junctional protein in a liver stem cell line and in the liver.Biochem Biophys Res Commun,2005,334(4):996-1003
    [57]Couchie D,Lafdil F,Martin-Garcia N,Laperche Y,Zafrani ES,Mavier P.Expression and role of Gas6 protein and of its receptor Axl in hepatic regeneration from oval cells in the rat.Gastroenterology,2005,129(5):1633-1642
    [58]Grozdanov PN,Yovchev MI,Dabeva MD.The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells.Lab Invest,2006,86(12):1272-1284
    [59]Gubin AN,Reddy B,Njoroge JM,Miller JL.Long-term,stable expression of green fluorescent protein in mammalian cells.Biochem Biophys Res Commun,1997, 236(2):347-350
    [60]Hong SH,Gang EJ,Jeong JA,Ahn C,Hwang SH,Yang IH,Park HK,Han H,Kim H.In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.Biochem Biophys Res Commun,2005,330(4):1153-1161
    [61]Germain L,Noel M,Gourdeau H,Marceau N.Promotion of growth and differentiation of rat ductular oval cells in primary culture.Cancer Res,1988,48(2):368-378
    [62]Lazaro CA,Rhim JA,Yamada Y,Fausto N.Generation of hepatocytes from oval cell precursors in culture.Cancer Res,1998,58(23):5514-5522
    [63]Jung Y,Oh SH,Zheng D,Shupe TD,Witek RP,Petersen BE.A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells.Lab Invest,2006, 86(5):477-489
    [64]Cirillo LA,Lin FR,Cuesta I,Friedman D,Jarnik M,Zaret KS.Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.Mol Cell,2002,9(2):279-289
    [65]Hasuike S,Ido A,Uto H,Moriuchi A,Tahara Y,Numata M,Nagata K,Hori T,Hayashi K, Tsubouchi H.Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.J Gastroenterol Hepatol,2005,20(11):1753-1761
    [66]Gordon GJ,Butz GM,Grisham JW,Coleman WB.Isolation,short-term culture,and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats.Transplantation,2002,73(8):1236-1243
    [67]Fiegel HC,Lange C,Kneser U,Lambrecht W,Zander AR,Rogiers X,Kluth D.Fetal and adult liver stem cells for liver regeneration and tissue engineering.J Cell Mol Med,2006, 10(3):577-587 [68Yang L,Li S,Hatch H,Ahrens K,Cornelius JG,Petersen BE,Peck AB.In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells.Proc Natl Acad Sci, 2002,99(12):8078-8083
    [69]Crosby HA,Fabris L,Joplin R,Kelly DA,Strain AJ.Immunolocalisation of OV-6 positive cells in normal and diseased human liver.Hepatology,1996,24(4):526-526
    [70]Alison M,Sarraf C.Hepatic stem cells.Journal of Hepatology,1998,29(4):676-682
    [71]Yavorkovsky L,Lai E,Ilic Z,Sell S.Participation of small intraportal stem cells in the restitutive response of the liver to periportal necrosis induced by allyl alcohol.Hepatology,1995,21(6):1702-1712
    [72]LeSage GD,Benedetti A,Glaser S,Marucci L,Tretjak Z,Caligiuri A,Rodgers R,Phinizy JL,Baiocchi L,Francis H,et al.Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver.Hepatology,1999,29(2):307-319
    [73]Strick-Marchand H,Weiss MC.Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos.Hepatology,2002,36(4 Pt 1):794-804
    [74]Sell S.Heterogeneity and plasticity of hepatocyte lineagecells.Hepatology,2001,33(3):738-750
    [75]Evarts RP,Nagy P,Nakatsukasa H,Marsden E,Thorgeirsson SS.In vivo differentiation of rat liver oval cells into hepatocytes.Cancer Res,1989,49(6):1541-1547
    [76]Paku S,Schnur J,Nagy P,Thorgeirsson SS.Origin and structural evolution of the early proliferating oval cells in rat liver.Am J Pathol,2001,158(4):1313-1323
    [77]Kobayashi N,Noguchi H,Fujiwara T,Tanaka N.Establishment of a reversibly immortalized human hepatocyte cell line by using Cre/loxP site-specific recombination.Transplant Proc,2000,32(5):1121-1122
    [78]Zajicek G,Arber N,Schwartz-Arad D.Streaming liver. VIII:Cell production rates following partial hepatectomy.Liver,1991,11(6):347-351
    [79]Dodat H,Sellem C,Pouillaude JM,Bouvier R,Takvorian P.Extensive congenital stenosis of the bulbo-membranous urethra in a child.Apropos of a case discovered in a newborn infant.Chir Pediatr,1987,28(2):125-128
    [80]Zajicek G,Oren R,Weinreb M,Jr.The streaming liver.Liver,1985,5(6):293-300
    [81]Susick R,Moss N,Kubota H,Lecluyse E,Hamilton G,Luntz T,Ludlow J,Fair J,Gerber D, Bergstrand K,et al.Hepatic progenitors and strategies for liver cell therapies.Ann N Y Acad Sci,2001,944:398-419
    [82]Jauregui HO.Hepatocyte cell lines as the biological component of liver support.Artif Organs,2001,25(7):509-512
    [83]Gordon GJ,Coleman WB,Hixson DC,Grisham JW.Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response.Am J Pathol,2000,156(2):607-619
    [84]Kucia M,Ratajczak J,Ratajczak MZ.Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells.Biol Cell,2005,97(2):133-146
    [85]Nardi NB.All the adult stem cells, where do they all come from?An external source for organ-specific stem cell pools.Med Hypotheses,2005,64(4):811-817
    [86]余宏宇,李文林,谢东甫,张朵,肖承志,孙志勇.小鼠单纯肝切除后再生肝组织内大小核分裂相和卵圆细胞的观察.第二军医大学学报,2005,26:261-266
    [87]Zhong XG,He S,Yin W,Deng JY,Cheng B.Selective tropism of liver stem cells to hepatocellular carcinoma in vivo.World J Gastroenterol,2007,13(28):3886-3891
    [88]Alison MR,Islam S,Lim S.Stem cells in liver regeneration,fibrosis and cancer:the good, the bad and the ugly.J Pathol,2009,217(2):282-298
    [89]Honczarenko M,Le Y,Swierkowski M,Ghiran I,Glodek AM,Silberstein LE.Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.Stem Cells,2006,24(4):1030-1041
    [90]Ho IA,Chan KY,Ng WH,Guo CM,Hui KM,Cheang P,Lam PY.Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma.Stem Cells,2009,27(6):1366-1375
    [91]Ma S,Chan KW,Hu L,Lee TK,Wo JY,Ng IO,Zheng BJ,Guan XY.Identification and characterization of tumorigenic liver cancer stem/progenitor cells.Gastroenterology,2007,132(7):2542-2556
    [92]Lee ES,Han EM,Kim YS,Shin BK,Kim CH,Kim HK,Won NH,Yeom BW,Kim I,Leong AS.Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.Am J Clin Pathol,2005,124(1):31-36
    [93]Fang CH,Gong JQ,Zhang W.Function of oval cells in hepatocellular carcinoma in rats.World J Gastroenterol,2004,10(17):2482-2487
    [94]Dumble ML,Croager EJ,Yeoh GC,Quail EA.Generation and characterization of p53 null transformed hepatic progenitor cells:oval cells give rise to hepatocellular carcinoma.Carcinogenesis,2002,23(3):435-445
    [95]Iidaka T,Tsukamoto T,Totsuka Y,Hirata A,Sakai H,Shirai N,Yamamoto M,Wakabayashi K,Yanai T,Masegi T,et al.Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice.Cancer Lett,2005,217(2):149-159
    [96]Yaswen P,Goyette M,Shank PR,Fausto N.Expression of c-Ki-ras,c-Ha-ras,and c-myc in specific cell types during hepatocarcinogenesis.Mol Cell Biol,1985,5(4):780-786
    [97]Lemmer ER,de la Motte Hall P,Omori N,Omori M,Shephard EG,Gelderblom WC, Cruse JP,Barnard RA,Marasas WF,Kirsch RE,et al.Histopathology and gene expression changes inrat liver during feeding of fumonisin B1,a carcinogenic mycotoxin produced by Fusarium moniliforme.Carcinogenesis,1999,20(5):817-824
    [98]Reya T,Morrison SJ,Clarke MF,Weissman IL.Stem cells,cancer,and cancer stem cells.Nature,2001,414(6859):105-111
    [99]Krause DS,Theise ND,Collector MI,Henegariu O,Hwang S,Gardner R,Neutzel S, Sharkis SJ.Multi-organ,multi-lineage engraftment by a single bone marrow-derived stem cell.Cell,2001,105(3):369-377
    [100]Baumann U,Crosby HA,Ramani P,Kelly DA,Strain AJ.Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver:identification of a human hepatic progenitor cell?Hepatology,1999, 30(1):112-117
    [101]Lemmer ER,Shepard EG,Blakolmer K,Kirsch RE,Robson SC.Isolation from human fetal liver of cells co-expressing CD34 haematopoietic stem cell and CAM 5.2 pancytokeratin markers.J Hepatol,1998,29(3):450-454
    [102]Petersen BE,Grossbard B,Hatch H,Pi L,Deng J,Scott EW.Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers.Hepatology,2003,37(3):632-640
    [103]Fukuda K,Sugihara A,Nakasho K,Tsujimura T,Yamada N,Okaya A,Sakagami M,Terada N.The origin of biliary ductular cells that appear in the spleen after transplantation of hepatocytes.Cell Transplant,2004,13(1):27-33
    [104]Minguet S,Cortegano I,Gonzalo P,Martinez-Marin JA,de Andres B,Salas C,Melero D,Gaspar ML,Marcos MA.A population of c-Kit(low)(CD45/TER119)-hepatic cell progenitors of 11-day postcoitus mouse embryo liver reconstitutes cell-depleted liver organoids.J Clin Invest,2003,112(8):1152-1163
    [105]Wu X,Zhao L,Xu Q,Zhang Y,Tang H.Differentiation of bone marrow mesenchymal stem cells into hepatocytes in hepatectomized mouse.Sheng Wu Yi Xue Gong Cheng Xue Za Zhi,2005,22(6):1234-1237
    [106]Jang YY,Collector MI,Baylin SB,Diehl AM,Sharkis SJ.Hematopoietic stem cells convert into liver cells within days without fusion.Nat Cell Biol,2004,6(6):532-539
    [107]Yamazaki S,Miki K,Takayama T,Hasegawa K,Sata M,Midorikawa Y,Aburatani H,Makuuchi M.Hepatic gene induction in murine bone marrow after hepatectomy.J Hepatol,2006,44(2):325-333
    [108]Chen JZ,Hong H,Xiang J,Xue L,Zhao GQ.A selective tropism of transfused oval cells for liver.World J Gastroenterol,2003,9(3):544-546
    [109]Wu XZ,Chen D.Origin of hepatocellular carcinoma:role of stem cells.J Gastroenterol Hepatol,2006,21(7):1093-1098
    [110]Yang XR,Xu Y,Yu B,Zhou J,Qiu SJ,Shi GM,Zhang BH,Wu WZ,Shi YH,Wu B,et al.High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.Gut,2010,59(7):953-962
    [111]Qiao L,Xu Z,Zhao T,Zhao Z,Shi M,Zhao RC,Ye L,Zhang X.Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.Cell Res,2008,18(4):500-507
    [112]Qiao L,Zhao TJ,Wang FZ,Shan CL,Ye LH,Zhang XD.NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.Acta Pharmacol Sin,2008,29(3):333-340
    [113]Qiao L,Xu ZL,Zhao TJ,Ye LH,Zhang XD.Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling.Cancer Lett,2008,269(1):67-77
    [114]Studeny M,Marini FC,Dembinski JL,Zompetta C,Cabreira-Hansen M,Bekele BN,Champlin RE,Andreeff M.Mesenchymal stem cells:potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.J Natl Cancer Inst,2004,96(21):1593-1603
    [115]Li GC,Ye QH,Xue YH,Sun HJ,Zhou HJ,Ren N,Jia HL,Shi J,Wu JC,Dai C et al.Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.Cancer Sci,2010,101(12):2546-2553
    [116]Tsai RY.A molecular view of stem cell and cancer cell self-renewal.Int J Biochem Cell Biol,2004,36(4):684-694
    [117]Reya T,Clevers H.Wnt signalling in stem cells and cancer.Nature,2005,434(7035):843-850
    [118]Menon LG,Picinich S,Koneru R,Gao H,Lin SY,Koneru M,Mayer-Kuckuk P,Glod J,Banerjee D.Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.Stem Cells,2007,25(2):520-528
    [119]Shimizu H,Julius MA,Giarre M,Zheng Z,Brown AM,Kitajewski J.Transformation by Wnt family proteins correlates with regulation of beta-catenin.Cell Growth Differ,1997, 8(12):1349-1358
    [120]Hatsell S,Rowlands T,Hiremath M,Cowin P.Beta-catenin and Tcfs in mammary development and cancer.J Mammary Gland Biol Neoplasia,2003,8(2):145-158
    [121]Pardal R,Clarke MF,Morrison SJ.Applying the principles of stem-cell biology to cancer.Nat Rev Cancer,2003,3(12):895-902
    [122]Weinstein M,Yang X,Deng C.Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.Cytokine Growth Factor Rev,2000,11(1-2):49-58
    [123]Chang H,Brown CW,Matzuk MM.Genetic analysis of the mammalian transforming growth factor-beta superfamily.Endocr Rev,2002,23(6):787-823
    [124]Massague J,Blain SW,Lo RS.TGFbeta signaling in growth control,cancer,and heritable disorders.Cell,2000,103(2):295-309
    [125]Higashiyama R,Inagaki Y,Hong YY,Kushida M,Nakao S,Niioka M,Watanabe T,Okano H,Matsuzaki Y,Shiota G,et al.Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.Hepatology,2007,45(1):213-222
    [126]苏娟,陶欣荣,朱海英,王新民,李建秀,田棣,余宏宇,Joseph T Lau,胡以平.人胎肝干细胞在重症联合免疫缺陷小鼠损伤肝脏中的植入.第二军医大学学报,2005, 26:243-246
    [127]Shi Z,Liang XL,Lu BX,Pan SY,Chen X,Tang QQ,Wang Y,Huang F.Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation.World J Gastroenterol,2005,11(24):3691-3695
    [128]Kushida T,Inaba M,Hisha H,Ichioka N,Esumi T,Ogawa R,Iida H,Ikehara S.Crucial roleof donor-derived stromal cells in successful treatment for intractable autoimmune diseases in mrl/lpr mice by bmt via portal vein.Stem Cells,2001,19(3):226-235
    [129]Song S,Witek RP,Lu Y,Choi YK,Zheng D,Jorgensen M,Li C,Flotte TR,Petersen BE.Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice.Hepatology,2004,40(4):918-924
    [130]Enns GM,Millan MT.Cell-based therapies for metabolic liver disease.Mol Genet Metab,2008,95(1-2):3-10
    [131]Mishra L,Banker T,Murray J,Byers S,Thenappan A,He AR,Shetty K,Johnson L,Reddy EP.Liver stem cells and hepatocellular carcinoma.Hepatology,2009,49(1):318-329
    [132]Ueki T,Kaneda Y,Tsutsui H,Nakanishi K,Sawa Y,Morishita R,Matsumoto K,Nakamura T,Takahashi H,Okamoto E,et al.Hepatocyte growth factor gene therapy of liver cirrhosis in rats.Nat Med,1999,5(2):226-230
    [133]Horiguchi K,Hirano T,Ueki T,Hirakawa K,Fujimoto J.Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery.J Hepatobiliary Pancreat Surg,2009,16(2):171-177
    [134]Chen XC,Wang R,Zhao X,Wei YQ,Hu M,Wang YS,Zhang XW,Zhang R,Zhang L,Yao B,et al.Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs.Carcinogenesis,2006,27(12):2434-2441
    [135]Fu X,He Y,Xie C,Liu W.Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage.Cytotherapy,2008,10(4):353-363
    [136]Kakinuma S,Nakauchi H,Watanabe M.Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease.J Gastroenterol,2009,44(3):167-172

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700